M&A: Page 10
-
Courtesy of SD Biosensor
SD Biosensor postpones closing of $1.53B Meridian acquisition to complete financing
SD Biosensor, a company known in the West for its work with Roche, struck the deal to buy Meridian in July to expand into the U.S. in vitro diagnostic market.
By Nick Paul Taylor • Dec. 14, 2022 -
Courtesy of Boston Scientific
Boston Scientific pays $523M for control of Chinese device maker Acotec
The acquisition will give Boston greater access to the Chinese market, which the U.S. firm expects will account for 25% of the global medtech demand by 2030.
By Peter Green • Dec. 12, 2022 -
Peter S Green/MedTech Dive
Q&AFriday Q&A: GE Healthcare’s Arduini, Zodl talk about spinoff, M&A, margins, Jack Welch
The CEO and CFO of the company spoke with MedTech Dive just weeks before the healthcare business formally separates from General Electric.
By Peter Green • Dec. 9, 2022 -
Carl Court via Getty Images
Cochlear’s $120M purchase of hearing-implant maker stirs European scrutiny
The European Commission said the merger “threatens to significantly affect competition in the market for cochlear implants and bone conduction solutions.”
By Nick Paul Taylor • Dec. 9, 2022 -
Courtesy of Indego
Ekso Bionics buys Indego lower limb exoskeleton business from Parker Hannifin for $10M
Indego and planned robotic assisted orthotic and prosthetic devices will slot into a portfolio of wearable robotics designed to tackle mobility loss.
By Nick Paul Taylor • Dec. 7, 2022 -
Johnny Greig via Getty Images
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
Courtesy of Integra
Integra to buy Surgical Innovation Associates for $50M in bid to lead growing breast reconstruction niche
Human-derived surgical matrices dominate the market but Interga thinks synthetic and xenograft devices will gain ground.
By Nick Paul Taylor • Dec. 2, 2022 -
Courtesy of GE Healthcare
GE’s board finalizes healthcare spinoff
The new company, GE Healthcare, will be the sixth largest global medtech company when it starts trading on Nasdaq on Jan. 4.
By Elise Reuter • Dec. 1, 2022 -
Boston Scientific to buy Apollo Endosurgery for $615M as entry into endobariatric market
The acquisition values Apollo shares at two-thirds above their closing price Monday, and may herald a new trend in medtech M&A, says an analyst.
By Elise Reuter • Nov. 29, 2022 -
Permission granted by ResMed
ResMed closes $1B Medifox buyout to expand software business into Europe
The takeover gives ResMed control of a 700-person operation that offers similar solutions to its existing U.S. brands MatrixCare and Brightree.
By Nick Paul Taylor • Nov. 23, 2022 -
Permission granted by Brittany Barreto
Q&AFriday Q&A: FemTech Focus’s Barreto discusses women’s health innovations, funding challenges
The executive director of the nonprofit group explains why women's health is finally getting attention and what the FemTech revolution is all about.
By Susan Kelly • Nov. 4, 2022 -
Courtesy of Abiomed
J&J to buy heart device maker Abiomed for $16.6B in year’s largest medtech deal
J&J will gain Abiomed’s heart pump devices amid a booming cardiac care market.
By Elise Reuter • Updated Nov. 2, 2022 -
Courtesy of Thermo Fisher Scientific
Thermo Fisher will buy The Binding Site for $2.6B to gain specialty diagnostics portfolio
The U.K.-based firm makes two blood tests for multiple myeloma.
By Elise Reuter • Oct. 31, 2022 -
Spencer Platt/Getty via Getty Images
Medtech M&A decline poised to continue in 2023 amid ‘bumpy’ market: report
Dealmaking has dropped as companies grapple with surging inflation and decreased spending by hospitals, according to EY.
By Elise Reuter • Oct. 26, 2022 -
Courtesy of AlertWatch
BioIntelliSense buys AlertWatch, expanding Medtronic patient monitoring partnership
Medtronic will distribute AlertWatch to hospitals in the U.S. alongside BioIntelliSense’s wearable device for continuous remote monitoring.
By Nick Paul Taylor • Oct. 25, 2022 -
Courtesy of Medtronic
Medtronic’s planned spinoff ‘doesn’t move the needle’ in growth strategy: analysts
Combining patient monitoring and respiratory intervention businesses into a separate company may not be enough to address investor concerns.
By Elise Reuter • Oct. 24, 2022 -
Courtesy of MedAlliance
Cordis to spend $235M to buy Swiss maker of alternative to paclitaxel balloons
As regulatory and sales milestones are hit, Cordis could pay up to $900 million in total.
By Nick Paul Taylor • Oct. 19, 2022 -
Courtesy of Qiagen
Bio-Rad, Qiagen are in talks over $10B merger, WSJ reports
While the two companies have been in talks for some time, the deal may fall through, the report said, citing people familiar with the matter.
By Ricky Zipp • Updated Oct. 11, 2022 -
Courtesy of Standard Bariatrics
Teleflex completes acquisition of Standard Bariatrics amid slow year for medtech M&A
The $170 million transaction reflects the selective nature of industry activity.
By Peter Green , Elise Reuter • Sept. 29, 2022 -
Permission granted by Clik-FIX
B. Braun acquires suite of catheter securement products from Starboard medical for undisclosed amount
The six acquired devices would improve patient care and extend B. Braun’s position in IV therapy, the company says.
By Elise Reuter • Sept. 28, 2022 -
Retrieved from Catheter Precision website on September 13, 2022
Catheter Precision agrees to reverse merger, securing cash to target cardiac electrophysiology market
By merging into Ra Medical Systems, Catheter Precision has access to public markets and a pool of cash needed to bring its product to market.
By Nick Paul Taylor • Sept. 13, 2022 -
Courtesy of Illumina
Illumina’s hold on Grail depends now on separate appeals in US, Europe
Even as it plans to appeal a European Commission decision and the FTC plans to appeal a U.S. ruling, Illumina say it’s preparing for ‘strategic alternatives’ to its acquisition of early cancer detection firm Grail.
By Elise Reuter • Updated Sept. 7, 2022 -
Retrieved from Olympus on August 30, 2022
Olympus to sell microscope unit for $3.1B as it bolsters focus on medical technology
Bain Capital has taken the other side of the deal, paying $3.1 billion for a business it said is “at the frontier of digital optical technology in life sciences and industrial end markets.”
By Nick Paul Taylor • Aug. 30, 2022 -
Retrieved from NJ Medical School Website on August 25, 2022
Labcorp adds to hospital lab buying streak with New Jersey acquisition
The purchase comes as hospitals work to trim costs and testing firms seek stable revenue streams as COVID-19 testing winds down.
By Peter Green , Rebecca Pifer • Aug. 25, 2022 -
Courtesy of Standard Bariatrics
Teleflex will buy Standard Bariatrics for $170M to gain Titan stapler
Standard’s investors could receive an additional $130 million if the unit reaches certain commercial milestones under Teleflex’s ownership.
By Elise Reuter • Aug. 22, 2022
Previous
